Bile acid

Jan 22, 2020

Metacrine Demonstrates Best-in-Class FXR Drug Program with Positive Clinical Results in NASH Patients

Jan 17, 2020

Latest IDEXX Innovations Designed to Enhance Patient Care and Drive Veterinary Productivity

Jul 09, 2019

Mirum Pharmaceuticals Initiates Phase 3 Clinical Trial for Pediatric Patients with Progressive Familial Intrahepatic Cholestasis

Apr 15, 2019

Mirum Pharmaceuticals Presents New Data Demonstrating Durable Improvements in Clinical Outcome Measures in Patients with PFIC2 and Alagille Syndrome Treated with Maralixibat

Mar 27, 2019

Mirum Pharmaceuticals to Present Phase 2 Clinical Results of Maralixibat in Alagille Syndrome and Progressive Familial Intrahepatic Cholestasis at the International Liver Congress

Nov 07, 2018

Mirum Pharmaceuticals Secures $120 Million in Series A Financing to Develop Phase 3-Ready Maralixibat for Rare Liver Diseases

Jul 24, 2018

Advances Along The Gut-Liver-Brain Axis In Alzheimer's Disease: Why Diet May Be So Impactful

Oct 10, 2017

Metacrine's FXR Program to be Highlighted in Three Abstracts at The Liver Meeting® 2017 in Washington, D.C.